Bryce Chaney

Leveraged digital technology platforms to convert warm leads into loyal clients through personalized, consultative communication. Screened 15+ insurance carriers to match client needs with tailored financial protection solutions.

Led all prospecting, sales, marketing, and select fundraising for an AI-generated peptide nanoparticle drug delivery startup. Built Tier 1 client targeting strategies and initiated technical discussions with 12 gene editor and CRISPR technology companies.

Generated over $10M in proposal value within the first 4 months, effectively selling a government biologics GMP manufacturer to near capacity. Analyzed COVID, vaccine, and biologics markets to identify and prioritize optimal target companies for rapid outreach.

Managed a global business development pipeline exceeding $45M with 30+ active prospects and 4–5 concurrent proposal defense discussions for biologic drug substance manufacturing. Coordinated new client acquisition, CDAs, technical due diligence, proposal negotiations, and project kick-offs.

Led global identification of new opportunities for laboratory testing services in the blood plasma industry, targeting multi-year agreements exceeding $10M/year. Directed the NGI 2.0 rebranding initiative, developing a new website, presentations, and proposals.

Organized the complete sales lifecycle for immuno-oncology drug development services, securing worldwide projects individually exceeding $100,000. Established formal sales processes, RFP response procedures, business metrics, and the entire sales and marketing budget from the ground up.

Actively managed ~25 sales pipeline opportunities across sterile, cytotoxic, ADC, Sterile/Lyo, and OSD product lines, driving a total proposal value exceeding $90M. Secured 60+ CDAs and evaluated 75+ RFI/RFPs; negotiated MSAs and commercial terms for manufacturing programs valued up to $30M.

Achieved $4.93M in sales across solid-state chemistry, analytical, formulation development, and API lines in just 3 quarters while maintaining a consistent $2M+ pipeline. Managed 150+ active clients, acquired 13 new high-value accounts, and facilitated 125+ face-to-face meetings.

Grew annual sales from $3.1M (2009) to $4.5M (2010) during turbulent market conditions, selling manufacturing lines to capacity in 14 months. Added $11M+ in project revenue by diversifying into biopolymer and inorganic synthesis, acquiring 26 new clients.

Held responsibility for $5M in business development activities.

Grew revenues by more than 50% year-over-year.

Served as Patent Liaison and Scientist, contributing to patent and scientific activities.

Master of Business Administration with concentrations in Strategy, Marketing, Innovation & Entrepreneurship.

Certificate in Consultative Medical Device Sales with focus on Orthobiologics and Regenerative Medicine.

Grade: Cum Laude

Activities and societies: Biology Minor; Honors Research Program

Bachelor of Science in Chemistry/Biochemistry with Honors and Cum Laude, including a Biology minor and participation in the Honors Research Program.